Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial-Reference-Cited by-同舟云学术

Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial

Published:2022-05 Issue: Volume:247 Page:33-41
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Klingenberg Roland^ORCID,Stähli Barbara E.,Heg Dik,Denegri Andrea^ORCID,Manka Robert,Kapos Ioannis,von Eckardstein Arnold,Carballo David,Hamm Christian W.,Vietheer Julia,Rolf Andreas,Landmesser Ulf,Mach François,Moccetti Tiziano,Jung Christian,Kelm Malte,Münzel Thomas^ORCID,Pedrazzini Giovanni,Räber Lorenz,Windecker Stephan,Matter Christian M.,Ruschitzka Frank,Lüscher Thomas F.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities;Andreadou;Cardiovasc Res,2019

2. Atherosclerosis;Libby;Nat Rev Dis Primers,2019

3. Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction;Westman;J Am Coll Cardiol,2016

4. Final infarct size measured by cardiovascular magnetic resonance in patients with ST elevation myocardial infarction predicts long-term clinical outcome: an observational study;Lønborg;Eur Heart J Cardiovasc Imaging,2013

5. Microvascular obstruction: underlying pathophysiology and clinical diagnosis;Bekkers;J Am Coll Cardiol,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Risk in HIV Patients: Ageing Analysis of the Involved Genes;Applied Sciences;2024-08-26

2. Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromes;European Heart Journal;2023-08-26

3. Inflammatory Mediators of Endothelial Dysfunction;Life;2023-06-20

4. Signaling Pathways in Inflammation and Cardiovascular Diseases: An Update of Therapeutic Strategies;Immuno;2022-11-11

5. Mammalian Target of Rapamycin Inhibition in Patients With ST-Segment Elevation Myocardial Infarction;Journal of the American College of Cardiology;2022-11